3701 - 3725 of 8587 Results
Title
Year
- Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's disease2022OPENTitle: Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1039214Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.1039214/pdfCitation Count: 8
- A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data2021OPENTitle: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.705407Best OA location URL: https://escholarship.org/content/qt2tv8r5dg/qt2tv8r5dg.pdfCitation Count: 61
- ModFus-PD: synergizing cross-modal attention and contrastive learning for enhanced multimodal diagnosis of Parkinson’s disease2025OPENTitle: ModFus-PD: synergizing cross-modal attention and contrastive learning for enhanced multimodal diagnosis of Parkinson’s diseaseJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 19Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2025.1604399Best OA location URL: https://www.frontiersin.org/journals/computational-neuroscience/articles/10.3389/fncom.2025.1604399/pdfCitation Count: 0
- Potential cerebrospinal fluid metabolomic biomarkers and early prediction model for Parkinson’s disease2025OPENTitle: Potential cerebrospinal fluid metabolomic biomarkers and early prediction model for Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2025.1582362Best OA location URL: https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2025.1582362/pdfCitation Count: 0
- Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations2023OPENTitle: Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutationsJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2023.1229213Best OA location URL: https://doi.org/10.3389/fncel.2023.1229213Citation Count: 7
- Association of Family History and Polygenic Risk Score With Longitudinal Prognosis in Parkinson Disease2023OPENTitle: Association of Family History and Polygenic Risk Score With Longitudinal Prognosis in Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000200115Best OA location URL: https://www.neurology.org/doi/pdfdirect/10.1212/NXG.0000000000200115Citation Count: 2
-
OPENTitle: Genome Sequencing in the Parkinson Disease ClinicJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/nxg.0000000000200002Best OA location URL: https://ng.neurology.org/content/nng/8/4/e200002.full.pdfCitation Count: 15
-
OPENTitle: Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor SubtypesJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000557Best OA location URL: https://ng.neurology.org/content/nng/7/2/e557.full.pdfCitation Count: 38
- Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s2023OPENTitle: Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’sJournal Name: Journal of Patient-Reported OutcomesPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s41687-023-00577-9Best OA location URL: https://jpro.springeropen.com/counter/pdf/10.1186/s41687-023-00577-9Citation Count: 11
- Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders2023OPENTitle: Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disordersJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-023-01653-3Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-023-01653-3Citation Count: 33
- DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s disease2024OPENTitle: DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s diseaseJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-024-00421-0Best OA location URL: https://link.springer.com/content/pdf/10.1186/s40035-024-00421-0.pdfCitation Count: 5
- Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease2023OPENTitle: Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s diseaseJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-023-00374-wBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-023-00374-wCitation Count: 23
- Moderating effects of uric acid and sex on cognition and psychiatric symptoms in asymmetric Parkinson’s disease2023OPENTitle: Moderating effects of uric acid and sex on cognition and psychiatric symptoms in asymmetric Parkinson’s diseaseJournal Name: Biology of Sex DifferencesPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13293-023-00510-1Best OA location URL: https://bsd.biomedcentral.com/counter/pdf/10.1186/s13293-023-00510-1Citation Count: 4
- Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease2022OPENTitle: Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s diseaseJournal Name: EJNMMI ResearchPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13550-022-00910-1Best OA location URL: https://ejnmmires.springeropen.com/counter/pdf/10.1186/s13550-022-00910-1Citation Count: 9
-
OPENTitle: The Clinical Profile of Tremor in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 10Start Page: 1496End Page: 1506Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13845Best OA location URL: https://pure.au.dk/ws/files/401874611/Movement_Disord_Clin_Pract_-_2023_-_Pasquini_-_The_Clinical_Profile_of_Tremor_in_Parkinson_s_Disease.pdfCitation Count: 13
- Co‐Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications2023OPENTitle: Co‐Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial ImplicationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 3Start Page: 312End Page: 314Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13890Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10928330Citation Count: 1
-
OPENTitle: Unanswered Questions in Clinical PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13837Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13837Citation Count: 0
-
OPENTitle: Status of Current Biofluid Biomarkers in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13753Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/129170Citation Count: 4
- Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease2023OPENTitle: Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 896End Page: 902Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13726Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13726Citation Count: 1
-
OPENTitle: Predictors of Future Deep Brain Stimulation Surgery in de novo Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 933End Page: 942Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13747Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10272891Citation Count: 1
- Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits2024OPENTitle: Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficitsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 34Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adn6016Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adn6016Citation Count: 8
- Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines2023OPENTitle: Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokinesJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 16Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.ade1282Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.ade1282Citation Count: 32
-
OPENTitle: clrDV: a differential variability test for RNA-Seq data based on the skew-normal distributionJournal Name: PeerJPublisher: PeerJVol: 11Issue #:Start Page: e16126End Page: e16126Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7717/peerj.16126Best OA location URL: https://peerj.com/articles/16126.pdfCitation Count: 1
-
OPENTitle: Retracted: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 2Start Page: 320End Page: 331Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25788Best OA location URL: https://pub.dzne.de/record/153306Citation Count: 94
- Differential transcript usage unravels transcriptional alterations in Alzheimer's disease human brains2020OPENTitle: Differential transcript usage unravels transcriptional alterations in Alzheimer's disease human brainsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.038695Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.038695Citation Count: 0